MedInvest is hosting a MedTech, AI & Digital Health Conference December 10-11, 2025 in New York City. NIH National Cancer Institute’s Michael Salgaller will be speaking. He will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is a great opportunity to hear from an expert on technology transfer at the NIH. Salgaller has in-depth knowledge of how the licensing and collaboration process works as well as information on the available technologies from all NIH institutes and centers.

Salgaller leads the Technology Analysis and Marketing Unit (TAMU) within the Technology Transfer Center at the NCI. He has over 20 years of scientific and investment experience and is ready to help foster licensing and collaboration activities between your organization and NIH.

Registration is through the MedInvest Conferences website. The event will be held in person and feature 40+ presenting companies, one-on-one meetings, and access to a partnering system.

In the meantime, take a look at the available technologies for licensing or collaboration from the NIH.